07:21:40 EDT Thu 22 Oct 2026
Enter Symbol
or Name
USA
CA



LSL Pharma Group Inc.
Symbol LSL
Shares Issued 126,729,818
Close 2026-10-21 C$ 0.295
Market Cap C$ 37,385,296
Recent Sedar+ Documents

ORIGINAL: LSL PHARMA GROUP INC. TO PRESENT AT THE "PLANET MICROCAP TORONTO 2026"

2026-10-22 07:00 ET - News Release

LSL PHARMA GROUP INC. TO PRESENT AT THE "PLANET MICROCAP TORONTO 2026"

Canada NewsWire

LSL PHARMA GROUP INC. Logo

BOUCHERVILLE, QC, Oct. 22, 2026 /CNW/ -- LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced it will be presenting at the Planet MicroCap Toronto 2026 powered by MicroCapClub on Wednesday, October 28 at 12:30 PM Local Time -EST) at the Arcadian Loft in Toronto. François Roberge, President & CEO of LSL Pharma will be hosting the presentation and answering questions afterwards.

To access the live presentation, please use the following information:

Event:

Planet MicroCap Toronto 2026 Powered by MicroCapClub



Date: 

Wednesday, October 28, 2026



Time:

12:30 PM (Toronto Local Time EST)



Webcast:

https://event.summitcast.com/view/iiVo9HYfz9sL9CC5m4Dgpv/o5yJVuWPX82XENsNNC3qqh

If you would like to book one-on-one investor meetings with LSL Pharma, please make sure you are registered here: REGISTER

One-on-one meetings will be scheduled and conducted in person at the conference venue: Arcadian Loft in Toronto, Ontario.

The Planet MicroCap Toronto 2026 website is available here: HOME PAGE

If you cannot attend the live presentation, the Corporation's presentation "webcast" will be available directly on the conference event platform on this link under the tab "Agenda": AGENDA

About LSL Pharma Group Inc.

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. Leveraging its technical expertise, certified facilities, and experienced team, LSL Pharma delivers high-quality solutions that meet the highest industry standards. The wholly-owned subsidiaries of LSL Pharma include Steri-Med Pharma Inc., LSL Laboratory Inc., Virage Santé Inc., Dermolab Pharma Ltd., Laboratoire Du-Var Inc. and LSL MedPlus Inc. (formerly Juno OTC Inc.) For more information, please visit our website at at www.groupelslpharma.com.

About Planet MicroCap

Planet Microcap hosts the highest quality microcap in-person events in North America. The mission is to bring the best microcap investors, companies, and allocators together to gather, connect, and grow. For more information about Planet MicroCap, please visit: https://planetmicrocap.com/ 

About MicroCapClub

MicroCapClub is an exclusive forum for experienced microcap investors to share and discuss microcap companies (sub $1 billion market cap) trading on global markets. Since 2011, our members have profiled 1500+ microcap companies. For more information, visit https://microcapclub.com/.

SOURCE Groupe LSL PHARMA INC.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2026/22/c2491.html

Contact:

François Roberge, President and Chief Executive Officer, (514) 664-7700, E-mail : Investors@groupelslpharma.com

© 2026 Canjex Publishing Ltd. All rights reserved.